Preoperative immunotherapy for mesothelioma shows favorable outcomes

Research scientist with gloves holding blood sample on glass in laboratory. Biology doctor analyzing plasma dna for medical discovery in pharmaceutical industry. Science equipment on desk

In a study published recently in the journal Clinical Cancer Research, researchers at Baylor College of Medicine found that treating patients who have resectable malignant pleural mesothelioma, meaning that their tumor can be removed with surgery, with immunotherapy ahead of surgery resulted in favorable clinical outcomes. The study lays the groundwork for neoadjuvant immunotherapy in mesothelioma.

Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma

Previous article

New look at an ancient disease: Study finds novel treatment targets for gout

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations